A Cautionary Note For Lawyers In Asbestos Litigation

Law360, New York (March 7, 2014, 5:36 PM EST) -- For a variety of reasons, lawyers in asbestos litigation are increasingly presented with fewer records and less medical evidence to evaluate malignant pleural mesothelioma claims. Frequently, the only material provided — and sometimes the only material available — is from a cytological diagnosis made from cells obtained from a pleural effusion, and not from a biopsy of the tumor itself.

Diagnosing malignant pleural mesothelioma from cytology alone is extremely difficult for even the most seasoned cytopathologist, yet many participants in the tort system fail to adequately...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.